Search
for
Sort by
Research 30 of 1000+
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma
- From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots
- Hair loss and Hedgehog inhibitors: a class effect?
- The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target
- 139 Anti-BCC efficacy of a topical hedgehog inhibitor without adverse effects in BCNS patients in a phase 2 randomized controlled trial
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Non-surgical treatments for basal cell skin cancer
- Aberrant Wnt Signaling Induces Comedo-Like Changes in the Murine Upper Hair Follicle
- Drug-induced scarring and permanent alopecia
- Disproportionality analysis comparing safety profiles of sonidegib and vismodegib based on the FAERS database
- Understanding Cancer Cells of Origin in Cutaneous Tumors
- Dermatopathology Update
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report
- Trichoscopy and LC-OCT findings in sonidegib-induced alopecia in patients with advanced basal cell carcinoma
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Cutaneous adverse effects of targeted therapies
- 085 Dermal papilla cells control hair follicle matrix keratinocytes proliferation through versican
- Management of Dermatologic Toxicities